Evaluation of Pharmacokinetic Drug Interactions Between Gemigliptin (Dipeptidylpeptidase-4 Inhibitor) and Glimepiride (Sulfonylurea) in Healthy Volunteers

PURPOSE: Gemigliptin is approved for the treatment of type II diabetes mellitus. Sulfonylureas are commonly used in combination with other antidiabetic drugs to improve glycemic control. The objective of this study was to evaluate the pharmacokinetics, safety, and tolerability of gemigliptin and gli...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hee Youn, Kim, Yo Han, Kim, Mi Jo, Lee, Shi Hyang, Bang, Keunsu, Han, Song, Lim, Hyeong-Seok, Bae, Kyun-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153964/
https://www.ncbi.nlm.nih.gov/pubmed/24962635
http://dx.doi.org/10.1007/s40268-014-0054-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153964/
https://www.ncbi.nlm.nih.gov/pubmed/24962635
http://dx.doi.org/10.1007/s40268-014-0054-8

Ejemplares similares